Omega-3-carboxylic acids

奥米加-3羧酸

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameOmega-3-carboxylic acids
Drug Alias Nameω-3羧酸奥米伽-3羧酸欧米茄-3羧酸欧米加-3-羧酸Epanova
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid modulatorsPeroxisome proliferator-activated receptor α agonists
TargetsLipidPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsHypertriglyceridemiaDyslipidemiasCardiovascular Diseases +[6] 
Global Approved IndicationsHypertriglyceridemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/05/05
Country/TerritoryCzechiaBelgiumCanada +[24] 
CombinationsYes
Global Highest StatusWithdrawn
Highest Status in ChinaPending
Originator CompaniesAthena Bioscience Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Pharmaceutical Co LtdWake Forest University Health SciencesAstrazeneca Plc +[8] 
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaDyslipidemiasCardiovascular Diseases +[6] 

Other Information

ATC CodeC10AX
Related LinksWikipediaDrugBank